Saturday, Jun 20, 2026
Breaking
Search
El-Balad.com
El-Balad.com
  • Home
  • Business
  • Entertainment
  • News
  • Sports
  • Tech
  • World
Explore by Topics
Subscribe
El-Balad.comEl-Balad.com
Search
  • Business
  • Entertainment
  • News
  • Sports
  • Tech
  • World
© 2026 El-Balad.com. All Rights Reserved.
Subscribe Newsletter
  • Daily Stories
  • Stock Alerts
  • Full Access
Subscribe to our newsletter to get our newest articles instantly!

Leucovorin

FDA Approves Novo’s Leucovorin Amid Epstein Case Updates – Readout Newsletter
Business

FDA Approves Novo’s Leucovorin Amid Epstein Case Updates – Readout Newsletter

March 12, 2026
RFK Jr. Criticizes FDA’s Shift on Promising Autism Drug Leucovorin
Business

RFK Jr. Criticizes FDA’s Shift on Promising Autism Drug Leucovorin

March 11, 2026
FDA Approves Leucovorin for Rare Genetic Disorder, Excludes Autism Treatment
Business

FDA Approves Leucovorin for Rare Genetic Disorder, Excludes Autism Treatment

March 11, 2026
FDA Broadens Leucovorin Use, Excluding Autism Treatment
Business

FDA Broadens Leucovorin Use, Excluding Autism Treatment

March 10, 2026
FDA Authorizes New Leucovorin Use, Excludes Autism Treatment
Business

FDA Authorizes New Leucovorin Use, Excludes Autism Treatment

March 10, 2026
Leucovorin Recast: 71% Surge in Child Prescriptions Exposes the Cost of FDA Mixed Messaging
News

Leucovorin Recast: 71% Surge in Child Prescriptions Exposes the Cost of FDA Mixed Messaging

March 10, 2026

The Daily Newsletter

Brings you a selection of the latest news, trends, insights, and tips from around the world.
El-Balad.com
El-Balad.com is your trusted source for comprehensive and balanced news coverage. With a commitment to integrity and accuracy, we provide in-depth reporting that uncovers the stories that matter most.
  • Business
  • Entertainment
  • News
  • Sports
  • Tech
  • World

More Links

  • About
  • Contact
  • Privacy